Genomatix, USU Seek to Use NGS to Find Prostate Cancer Prognostic Markers | GenomeWeb

Genomatix Software, the Uniformed Service University of the Health Sciences, and the Henry M. Jackson Foundation for the Advancement of Military Medicine will collaborate on a project to use next-gen sequencing to help identify biomarkers for prostate cancer prognostics.

The goal of the collaboration is to identify biomarkers that can be used to help predict the outcome of prostate cancer patients at the time of diagnosis, which is currently difficult to do.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.